Search Results - "Power, Danielle"
-
1
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models
Published in EBioMedicine (01-03-2022)“…Surveillance is universally recommended for non-small cell lung cancer (NSCLC) patients treated with curative-intent radiotherapy. High-quality evidence to…”
Get full text
Journal Article -
2
Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24
Published in Journal of medical genetics (01-03-2012)“…Five single nucleotide polymorphisms (SNPs) associated with thyroid cancer (TC) risk have been reported: rs2910164 (5q24); rs6983267 (8q24); rs965513 and…”
Get more information
Journal Article -
3
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients
Published in European journal of nuclear medicine and molecular imaging (01-02-2019)“…Purpose The aim of this multi-center study was to discover and validate radiomics classifiers as image-derived biomarkers for risk stratification of…”
Get full text
Journal Article -
4
Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Published in NPJ precision oncology (27-10-2022)“…Recurrence occurs in up to 36% of patients treated with curative-intent radiotherapy for NSCLC. Identifying patients at higher risk of recurrence for more…”
Get full text
Journal Article -
5
Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
Published in NPJ precision oncology (23-11-2022)Get full text
Journal Article -
6
166 - Use of sotorasib in KRAS p.G12C mutated NSCLC: a case report
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2022)Get full text
Journal Article -
7
Use of sotorasib in KRAS p.G12C mutated NSCLC: a case report
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2022)Get full text
Journal Article -
8
Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
Published in JAMA oncology (01-12-2019)“…Gut dysbiosis impairs response to immune checkpoint inhibitors (ICIs) and can be caused by broad-spectrum antibiotic (ATB) therapy. To evaluate whether there…”
Get more information
Journal Article -
9
214 Rowell Syndrome as a Paraneoplastic Manifestation of Metastatic Mesothelioma
Published in Lung cancer (Amsterdam, Netherlands) (01-04-2024)Get full text
Journal Article -
10
A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC
Published in Journal of thoracic oncology (01-06-2023)“…Patient selection for checkpoint inhibitor immunotherapy is currently guided by programmed death-ligand 1 (PD-L1) expression obtained from immunohistochemical…”
Get more information
Journal Article -
11
Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis
Published in Radiotherapy and oncology (01-06-2024)“…•Accurate differentiation between checkpoint inhibitor, radiation, and infective pneumonitis is crucial but challenging.•Correct diagnosis is made difficult by…”
Get full text
Journal Article -
12
-
13
-
14
-
15
-
16
-
17
-
18
Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS)
Published in International journal of epidemiology (01-12-2018)“…Occupational and environmental airborne asbestos concentrations are too low and variable for lifetime exposures to be estimated reliably, and building workers…”
Get full text
Journal Article -
19
-
20